Patients reported more pain, inflammation with aflibercept, study finds

HONOLULU — At the Association for Research in Vision and Ophthalmology meeting here, Arshad Khanani, MD, discusses early results of the SOLAR study, which evaluated and compared pain and inflammation in patients treated with Eylea (aflibercept, Regeneron) or Lucentis (ranibizumab, Genentech).

Full Story →